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Abstract
Introduction: Choroidal melanoma and choroidal metastasis are distinct pathological entities
with very different treatments and prognoses. They may be difficult to distinguish to the untrained
observer.
Case presentation: A case of concomitant choroidal melanoma in a woman with primary breast
carcinoma is described. The choroidal lesion was thought initially to be a metastasis, and treated
with external beam radiotherapy. The tumour did not regress but remained stable in size for a
period of three years. Following referral to an ophthalmologist, the diagnosis was revised after re-
evaluation of the clinical, ultrasonographic and angiographic findings.
Conclusion: Although metastases are the most common ocular tumour, a differential diagnosis of
a concurrent primary ocular malignancy should always be considered, even in patients with known
malignant disease. Thorough ophthalmic evaluation is important, as multiple primary malignancies
may occur concomitantly. The prognostic and therapeutic implications of accurate diagnosis by an
ophthalmologist are of profound significance to affected patients and their families.
Introduction
Choroidal melanoma and choroidal metastasis are dis-
tinct pathological entities with very different treatments
and prognoses. They may be difficult to distinguish to the
untrained observer. A case of concomitant choroidal
melanoma in a woman with primary breast carcinoma is
described. The choroidal lesion was thought initially to be
a metastasis, and treated with external beam radiotherapy.
The tumour did not regress but remained stable in size for
a period of three years. Following referral to an ophthal-
mologist, the diagnosis was revised after re-evaluation of
the clinical, ultrasonographic and angiographic findings.
Case presentation
A 76 year old woman underwent mastectomy for a pri-
mary breast malignancy, shown histologically to be a low
grade ductal adenocarcinoma (stage T1 N0). Three months
after surgery, she complained of visual deterioration in
her right eye. A lesion was identified on fundoscopy by
the treating oncologists, and a presumptive diagnosis of
choroidal metastasis from the breast malignancy was
made without ophthalmic consultation. Palliative exter-
nal beam radiotherapy (EBRT) (20 Gy total) was adminis-
tered to the right orbit in five daily fractions. The patient
was kept under regular review by her oncologist and
remained stable with no enlargement of the lesion
reported on serial magnetic resonance imaging.
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referred to our ophthalmic service due to failing vision in
the right eye. Corrected visual acuity was 6/18 in the
affected eye. Dilated examination using a slit lamp
revealed an 11 × 10 mm elevated choroidal mass in the
peripheral fundus, mainly yellow in color with some
intrinsic pigmentation (Figure 1) and with no associated
sub-retinal fluid. B-scan ultrasonography showed a mush-
room shaped lesion, choroidal excavation due to exten-
sion through Bruch's membrane and low internal
reflectivity (Figure 2). Fluorescein angiography demon-
strated a "double circulation" (Figure 3) with intrinsic vas-
culature seen within the tumour, and the larger normal
retinal vessels seen more superficially. Examination of the
left eye was unremarkable.
A revised diagnosis was made of a primary choroidal
melanoma, partially treated by radiotherapy, in the pres-
ence of a concomitant primary breast malignancy. Mag-
netic resonance imaging of the brain, chest radiographs
and liver function tests demonstrated no evidence of met-
astatic disease. The patient declined further intervention
initially and conservative management was initiated.
Three years later, growth of the lesion was observed and
the patient was referred to a regional ocular oncology serv-
ice. Enucleation was performed, over four years after the
initial observation of the ocular lesion, confirming the
diagnosis of choroidal melanoma. To date, five years since
initial detection of the lesion, the patient remains well
with no evidence of metastatic melanoma.
Discussion
Metastatic disease is the most common ocular malig-
nancy. Shields et al performed a retrospective survey of
520 eyes with uveal metastases of which 88% were within
the choroid [1]. 66% of these cases had a known primary
carcinoma, the most common sources being breast (47%)
followed by lung (21%). Of the remainder, a primary
malignancy was identified in only 50% of cases. Meta-
static lesions in the choroid were typically yellow in col-
our, plateau shaped, associated with sub-retinal fluid and
had a mean thickness of 3 mm.
Prospective follow up of patients enrolled in the Collabo-
rative Ocular Melanoma Study (COMS) Group found that
7.7% of patients were diagnosed with a secondary pri-
mary malignancy over five years of follow up, with pros-
tate (23%) and breast (17%) being most commonly
reported [2].
Sobttka et al examined B-scan ultrasonographic findings
in order to distinguish metastases in the choroid from pri-
mary malignant melanoma [3]. Choroidal excavation,
low internal reflectivity and a high height:base ratio were
considered to be virtually pathognomonic for choroidal
melanoma. However "mushroom shaped" choroidal
metastases have been reported [4,5], although these
showed higher internal reflectivity on ultrasonography.
Studies of patients with choroidal metastases from pri-
mary breast carcinoma have reported a mean life expect-
ancy of nine months following ocular diagnosis [6,7]. It is
important to note that metastases exhibited bilaterality in
40% of cases and tended to follow pulmonary dissemina-
B-scan ultrasound of the right eye showing the tumourFigure 2
B-scan ultrasound of the right eye showing the 
tumour. The arrow points to excavation of the choroid by 
the invading tissue.
A large mushroom shaped lesion with some intrinsic pigmen-tation seen on examination of the right fundusFigur  1
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involvement [7].
The prolonged survival of this patient following detection
of the choroidal tumour and the absence of metastatic dis-
ease at other sites further indicates that the ocular lesion
was unlikely to be a metastasis, and was in fact a primary
malignant melanoma whose growth had been arrested by
radiotherapy. In addition the intrinsic or "double" circu-
lation seen on fluorescein angiography in this case would
be very atypical for a metastasis (Figure 3).
Treatment options for a primary choroidal melanoma as
in this case would include brachytherapy, proton beam
radiotherapy or enucleation, whereas breast metastases
are often reviewed following systemic chemotherapy or
external beam radiotherapy.
20 Gy of EBRT would be regarded as a sub-optimal treat-
ment dose for choroidal melanoma. The 5 year
melanoma-specific mortality for adequately treated
medium sized choroidal melanoma has been reported at
10% by the COMS group [8] with undetectable microme-
tastases thought to occur early in the disease course, often
before conservative treatment of the primary tumour [9].
The patient declined further active treatment initially, opt-
ing for a conservative approach, although definitive treat-
ment was agreed upon following the detection of further
growth of the melanoma.
Conclusion
Although metastases are the most common ocular
tumour, a differential diagnosis of a concurrent primary
ocular malignancy should always be considered, even in
patients with known malignant disease. Thorough oph-
thalmic evaluation is important, as multiple primary
malignancies may occur concomitantly [10]. This is par-
ticularly important in the absence of either pulmonary or
central nervous system involvement as metastatic ocular
involvement usually occurs at an advanced stage. The
prognostic and therapeutic implications of accurate diag-
nosis by an ophthalmologist are of profound significance
to affected patients and their families.
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